A citation-based method for searching scientific literature

Kei Ohnuma, Osamu Hosono, Nam H Dang, Chikao Morimoto. Adv Clin Chem 2011
Times Cited: 52







List of co-cited articles
294 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck, Gordon S Howarth, Catherine A Abbott. Trends Pharmacol Sci 2009
182
25


Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function.
Kei Ohnuma, Nam H Dang, Chikao Morimoto. Trends Immunol 2008
170
19

Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease.
M Hildebrandt, M Rose, J Rüter, A Salama, H Mönnikes, B F Klapp. Scand J Gastroenterol 2001
61
19


Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.
Seoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, Michael Doherty, Allison B Goldfine, Daniel H Solomon. Ann Rheum Dis 2015
59
15

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?
Aleksi Sedo, Jonathan S Duke-Cohan, Eva Balaziova, Liliana R Sedova. Arthritis Res Ther 2005
57
13

DPP4 inhibitor-induced polyarthritis: a report of three cases.
Etienne Crickx, Ibrahim Marroun, Christine Veyrie, Christine Le Beller, Yoland Schoindre, Florence Bouilloud, Olivier Blétry, Jean-Emmanuel Kahn. Rheumatol Int 2014
33
21

Sitagliptin, a dipeptidyl peptidase-IV inhibitor, improves psoriasis.
Tatsuya Nishioka, Masayuki Shinohara, Noriyasu Tanimoto, Chizuru Kumagai, Kozo Hashimoto. Dermatology 2012
32
21

CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
R G van Lingen, P C M van de Kerkhof, M M B Seyger, E M G J de Jong, D W A van Rens, M K P Poll, P L J M Zeeuwen, P E J van Erp. Br J Dermatol 2008
36
19


Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
174
13

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.
Anne-Marie Lambeir, Christine Durinx, Simon Scharpé, Ingrid De Meester. Crit Rev Clin Lab Sci 2003
628
13


CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.
M D Gorrell, V Gysbers, G W McCaughan. Scand J Immunol 2001
278
11

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
A Steinbrecher, D Reinhold, L Quigley, A Gado, N Tresser, L Izikson, I Born, J Faust, K Neubert, R Martin,[...]. J Immunol 2001
124
11



Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).
Bertram Bengsch, Bianca Seigel, Tobias Flecken, Julia Wolanski, Hubert E Blum, Robert Thimme. J Immunol 2012
104
11

Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen.
Shuling Yan, Didier Marguet, Jörg Dobers, Werner Reutter, Hua Fan. Eur J Immunol 2003
88
11

Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.
J Béné, G Moulis, I Bennani, M Auffret, P Coupe, S Babai, D Hillaire-Buys, J Micallef, S Gautier. Br J Dermatol 2016
95
11

Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
C Klemann, L Wagner, M Stephan, S von Hörsten. Clin Exp Immunol 2016
187
11


CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
R Pacheco, J M Martinez-Navio, M Lejeune, N Climent, H Oliva, J M Gatell, T Gallart, J Mallol, C Lluis, R Franco. Proc Natl Acad Sci U S A 2005
174
9

On the origin of serum CD26 and its altered concentration in cancer patients.
Oscar J Cordero, Francisco J Salgado, Montserrat Nogueira. Cancer Immunol Immunother 2009
143
9

Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1.
Kei Ohnuma, Masahiko Uchiyama, Tadanori Yamochi, Kunika Nishibashi, Osamu Hosono, Nozomu Takahashi, Shinichiro Kina, Hirotoshi Tanaka, Xin Lin, Nam H Dang,[...]. J Biol Chem 2007
86
9

CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production.
Ryo Hatano, Kei Ohnuma, Junpei Yamamoto, Nam H Dang, Chikao Morimoto. Immunology 2013
51
9

Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.
Ulf Forssmann, Carsten Stoetzer, Michael Stephan, Carsten Kruschinski, Thomas Skripuletz, Jutta Schade, Andreas Schmiedl, Reinhard Pabst, Leona Wagner, Torsten Hoffmann,[...]. J Immunol 2008
75
9

Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV.
S Tanaka, T Murakami, H Horikawa, M Sugiura, K Kawashima, T Sugita. Int J Immunopharmacol 1997
90
9

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
9

Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice.
Roger Yazbeck, Gordon S Howarth, Mark S Geier, Hans-Ulrich Demuth, Catherine A Abbott. Front Biosci 2008
41
12

Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.
M Novelli, P Savoia, M T Fierro, A Verrone, P Quaglino, M G Bernengo. Br J Dermatol 1996
32
15

Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.
J D Price, G Linder, W P Li, B Zimmermann, K I Rother, R Malek, M Alattar, K V Tarbell. Clin Exp Immunol 2013
22
22

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
Nathalie Busso, Nicolai Wagtmann, Christian Herling, Veronique Chobaz-Péclat, Angelika Bischof-Delaloye, Alexander So, Eric Grouzmann. Am J Pathol 2005
158
9

CD26/dipeptidyl peptidase IV and its role in cancer.
B Pro, N H Dang. Histol Histopathol 2004
83
7

Role of CD26/dipeptidyl peptidase IV in human T cell activation and function.
Kei Ohnuma, Nozomu Takahashi, Tadanori Yamochi, Osamu Hosono, Nam H Dang, Chikao Morimoto. Front Biosci 2008
85
7

CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.
T Ishii, K Ohnuma, A Murakami, N Takasawa, S Kobayashi, N H Dang, S F Schlossman, C Morimoto. Proc Natl Acad Sci U S A 2001
128
7

Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
Hiroshi Kobayashi, Osamu Hosono, Tsuneyo Mimori, Hiroshi Kawasaki, Nam Hoang Dang, Hirotoshi Tanaka, Chikao Morimoto. J Rheumatol 2002
52
7

The role of CD26/dipeptidyl peptidase IV in cancer.
Pamela A Havre, Masako Abe, Yasuyo Urasaki, Kei Ohnuma, Chikao Morimoto, Nam H Dang. Front Biosci 2008
139
7

Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients.
C Muscat, A Bertotto, E Agea, O Bistoni, R Ercolani, R Tognellini, F Spinozzi, M Cesarotti, R Gerli. Clin Exp Immunol 1994
58
7

Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.
S J Khoury, C R Guttmann, E J Orav, R Kikinis, F A Jolesz, H L Weiner. Arch Neurol 2000
89
7

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
7



Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.
Pablo Aschner, Mark S Kipnes, Jared K Lunceford, Matilde Sanchez, Carolyn Mickel, Debora E Williams-Herman. Diabetes Care 2006
637
7

CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis.
R Gerli, C Muscat, A Bertotto, O Bistoni, E Agea, R Tognellini, G Fiorucci, M Cesarotti, S Bombardieri. Clin Immunol Immunopathol 1996
43
9

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
Noriko Satoh-Asahara, Yousuke Sasaki, Hiromichi Wada, Mayu Tochiya, Azusa Iguchi, Reiko Nakagawachi, Shinji Odori, Shigeo Kono, Koji Hasegawa, Akira Shimatsu. Metabolism 2013
130
7

The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
Yunjuan Zhao, Lin Yang, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2014
39
10

Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis.
Lucie Sromova, Helena Mareckova, Liliana Sedova, Eva Balaziova, Aleksi Sedo. Clin Chim Acta 2010
13
30

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea.
Yoshimasa Aso, Noriyuki Ozeki, Tomoko Terasawa, Rika Naruse, Kenji Hara, Mariko Suetsugu, Kohzo Takebayashi, Mitsuei Shibazaki, Kohsuke Haruki, Kimio Morita,[...]. Transl Res 2012
56
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.